Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections

By: Alex Zhavoronkov In: Aging Date: 31 March, 2020 Summary COVID-19 disproportionately harms the elderly. Infection rates, severity, and lethality all increase with age. Mostly because of higher levels of comorbidity among elderly. May also be due to decreased immune

Read More Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections

The Drive with Peter Attia — Matt Kaeberlein

On: Rapamycin and dogs — man’s best friends? Episode: 10 Date: August 2018 Key Subjects: Involved in dog ageing research project:Live in similar environment as humans.Die from similar diseases as humans (although cancer is the most common in dogs, versus

Read More The Drive with Peter Attia — Matt Kaeberlein

The Drive with Peter Attia — David Sabatini

On: Rapamycin and the discovery of mTOR — the nexus of aging and longevity? Episode: 9 Date: August 2018 Key Subjects: mTOR (mammalian target of rapamycin) (see mTOR write-up) Central regulator of metabolism and physiology. Regulating many cellular processes (cell

Read More The Drive with Peter Attia — David Sabatini

mTOR

Summary Introduction. mTOR Activation and Inhibition. Rapamycin. Sources. Introduction Mammalian target of rapamycin (mTOR). Involved in cell metabolism, survival, and growth Central regulator of metabolism and physiology. Regulates many cellular processes. Ccell growth, proliferation, protein synthesis, autophagy. Within the cell,

Read More mTOR